BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23332012)

  • 1. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Storer N; Labbato D; Clagett B; Robinson J; Lederman MM; McComsey GA
    Clin Infect Dis; 2014 Feb; 58(4):588-95. PubMed ID: 24253250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.
    Erlandson KM; OʼRiordan M; Labbato D; McComsey GA
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):290-8. PubMed ID: 24525466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
    Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
    Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    Butterfield TR; Hanna DB; Kaplan RC; Kizer JR; Durkin HG; Young MA; Nowicki MJ; Tien PC; Golub ET; Floris-Moore MA; Titanji K; Fischl MA; Heath SL; Martinson J; Crowe SM; Palmer CS; Landay AL; Anzinger JJ
    AIDS; 2017 Jan; 31(2):199-205. PubMed ID: 27835618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: Carotid Artery Plaque Burden in HIV Is Associated with Soluble Mediators and Monocytes.
    Chow DC; Mau M; Hodis HN; Kewcharoen J; Li Y; Siriwardhana C; Souza SA; Mitchell BI; Bowler S; SahBandar I; Gangcuangco LMA; MacPherson I; Ndhlovu LC; Shikuma CM
    AIDS Res Hum Retroviruses; 2020 Dec; 36(12):1020-1023. PubMed ID: 32862657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection.
    Zhao W; Wang X; Deik AA; Hanna DB; Wang T; Haberlen SA; Shah SJ; Lazar JM; Hodis HN; Landay AL; Yu B; Gustafson D; Anastos K; Post WS; Clish CB; Kaplan RC; Qi Q
    Circulation; 2019 Apr; 139(17):2003-2011. PubMed ID: 30759995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy.
    Longenecker CT; Jiang Y; Yun CH; Debanne S; Funderburg NT; Lederman MM; Storer N; Labbato DE; Bezerra HG; McComsey GA
    Int J Cardiol; 2013 Oct; 168(4):4039-45. PubMed ID: 23886531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.
    Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; Lumbreras B; Hernández I; Gutiérrez F
    PLoS One; 2014; 9(8):e105442. PubMed ID: 25133669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low CD4 Cell Counts Are Associated with Carotid Plaque and Intima-Media Thickness in Virologically Suppressed HIV-Infected Asians Older Than 50 Years.
    Siwamogsatham S; Chutinet A; Vongsayan P; Samajarn J; Putcharoen O; Aponpong T; Hiransuthikul A; Gatechompol S; Han WM; Chattranukulchai P; Kerr SJ; Ruxrungtham K; Avihingsanon A;
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1160-1169. PubMed ID: 31530175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.
    Dirajlal-Fargo S; Sattar A; Kulkarni M; Funderburg N; McComsey GA
    HIV Clin Trials; 2017 Jul; 18(4):156-163. PubMed ID: 28828963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: The Effect of Rosuvastatin on Vascular Disease Differs by Smoking Status in Treated HIV Infection.
    Hileman CO; McComsey GA
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):282-285. PubMed ID: 28974102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
    Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
    PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 19. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening.
    Alcaraz MJ; Alcaraz A; Teruel-Montoya R; Campillo JA; de la Torre A; Muñoz Á; Tomás C; Puche G; Báguena C; Cano A; Minguela A; Bernal E
    Aging (Albany NY); 2021 Jul; 13(14):18094-18105. PubMed ID: 34310343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
    Yong YK; Shankar EM; Westhorpe CLV; Maisa A; Spelman T; Kamarulzaman A; Crowe SM; Lewin SR
    Medicine (Baltimore); 2016 Aug; 95(31):e4477. PubMed ID: 27495090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.